Infectious Disease care
Auth57 · Specialty PA Pack

Infectious Disease

For the ID specialist on antiretrovirals, Hep C, and antifungals — prior auth and appeals, mapped nationwide.

Structured rules
1,835
PA-required
63%
Appeal layer
51/51
Criteria docs
51/51
The breadth · all 51 jurisdictions

Every state, quantified for infectious disease

StateRulesPA-requiredAppealCriteria docs
AKAlaska2665%5
ALAlabama3866%10
ARArkansas4065%13
AZArizona3866%12
CACalifornia4055%7
COColorado3861%15
CTConnecticut3866%4
DCDistrict of Columbia3861%12
DEDelaware3866%7
FLFlorida3866%7
GAGeorgia4163%34
HIHawaii3858%11
IAIowa3866%18
IDIdaho2962%12
ILIllinois3866%6
INIndiana3868%10
KSKansas3765%13
KYKentucky4166%6
LALouisiana3566%18
MAMassachusetts3263%6
MDMaryland3459%25
MEMaine3462%7
MIMichigan3560%23
MNMinnesota2959%15
MOMissouri4367%6
MSMississippi4065%16
MTMontana2966%6
NCNorth Carolina4163%47
NDNorth Dakota2861%8
NENebraska3566%6
NHNew Hampshire3465%3
NJNew Jersey3560%9
NMNew Mexico3060%9
NVNevada3462%28
NYNew York3964%26
OHOhio4271%29
OKOklahoma4163%10
OROregon4163%6
PAPennsylvania3563%19
RIRhode Island2962%4
SCSouth Carolina3866%13
SDSouth Dakota2756%4
TNTennessee3866%10
TXTexas4060%97
UTUtah3866%26
VAVirginia4163%22
VTVermont2662%18
WAWashington4156%16
WIWisconsin3868%10
WVWest Virginia3266%1
WYWyoming2966%10
Free preview· Texas

What a fully-unlocked state looks like

medicare traditional
  • hiv antiretroviralsNo PAOral ARVs covered under Part D PDP — no FFS Part B PA.
medicaid ffs
  • hiv antiretrovirals(HHSC)No PATX Medicaid: ALL-PREFERRED / protected class — no PDL prior authorization. Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
  • hepatitis c daaPA requiredTX Medicaid PDL: non-preferred agents require PA (step therapy). Source: Acentra TX PDL Criteria Guide 2026-01-30 (official companion to TX Medicaid PDL).
part d
  • hiv antiretroviralsNo PAFEDERAL PROTECTED CLASS. Plans must cover all or substantially all HIV ARVs without restrictive PA.
  • antifungals systemic(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
  • hepatitis c daa(Centene)PA requiredCentene Part D (CMS formulary file, plan-grounded).
  • hiv antiretrovirals(Centene)No PACentene Part D (CMS formulary file, plan-grounded).
  • antifungals systemic(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • hepatitis c daa(Unitedhealthcare)PA requiredUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • hiv antiretrovirals(Unitedhealthcare)No PAUnitedhealthcare Part D (CMS formulary file, plan-grounded).
  • hiv antiretrovirals(Humana)No PAHumana Part D (CMS formulary file, plan-grounded).
  • antifungals systemic(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • hepatitis c daa(Humana)PA requiredHumana Part D (CMS formulary file, plan-grounded).
  • hepatitis c daa(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
  • hiv antiretrovirals(Cigna)No PACigna Part D (CMS formulary file, plan-grounded).
  • antifungals systemic(Cigna)PA requiredCigna Part D (CMS formulary file, plan-grounded).
  • antifungals systemic(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
  • hepatitis c daa(Aetna)PA requiredAetna Part D (CMS formulary file, plan-grounded).
  • hiv antiretrovirals(Aetna)No PAAetna Part D (CMS formulary file, plan-grounded).
medicare advantage
  • hiv antiretroviralsNo PAHIV antiretrovirals are a Medicare Part D protected class (42 CFR 423.120(b)(2)(vi)); CMS prohibits prior authorization and step therapy on antiretrovirals (no new-start exception). PA not required.
dual eligible
  • hiv antiretroviralsNo PAPart D primary — protected class, broad access. LIS eliminates cost-sharing.
medicaid mco
  • hiv antiretrovirals(TX Medicaid)No PAstep therapymust not impede access to treatment
commercial regulated
  • antifungals systemic(UnitedHealthcare)PA requiredUnitedHealthcare commercial (Advantage 3-Tier). Antifungals-fungal infections; mostly QL but JUBLIA (PA,ST) and VIVJOA (PA) carry PA [e.g. fluconazole, itraconazole, terbinafine, JUBLIA]
  • hepatitis c daa(UnitedHealthcare)PA requiredUnitedHealthcare commercial (Advantage 3-Tier). Hep C DAAs within Antivirals heading; all carry PA+QL+SP (HARVONI/LEDIPASVIR-SOFOSBUVIR add ST) [e.g. EPCLUSA, HARVONI, MAVYRET, VOSEVI]
  • hiv antiretrovirals(UnitedHealthcare)No PAUnitedHealthcare commercial (Advantage 3-Tier). HIV ARVs within Antivirals heading; carry QL only (no PA); tenofovir DF carries H-PA preventive/PrEP flag, not standard PA [e.g. BIKTARVY, DOVATO, GENVOYA, TRIUMEQ]
  • hepatitis c daa(Cigna)PA requiredCigna commercial (Advantage 3-Tier). HCV direct-acting antivirals SP+PA [e.g. EPCLUSA, HARVONI, VOSEVI, ZEPATIER]
  • antifungals systemic(Cigna)PA requiredCigna commercial (Advantage 3-Tier). oral azoles mostly open; CRESEMBA/VIVJOA carry PA [e.g. fluconazole, itraconazole, CRESEMBA, VIVJOA]
  • hiv antiretrovirals(Cigna)PA requiredCigna commercial (Advantage 3-Tier). AIDS/HIV section; several agents carry PA (others SP/QL only) [e.g. CABENUVA, DELSTRIGO, STRIBILD, PIFELTRO]
  • hepatitis c daa(Aetna (CVS Caremark))PA requiredAetna (CVS Caremark) commercial formulary. HCV DAAs, specialty, PA standard [e.g. MAVYRET, EPCLUSA, sofosbuvir-velpatasvir, ZEPATIER]
  • hiv antiretrovirals(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. protected class; standard tiers, generally no PA [e.g. BIKTARVY, TRIUMEQ, DOVATO, TIVICAY]
  • antifungals systemic(Aetna (CVS Caremark))No PAAetna (CVS Caremark) commercial formulary. oral antifungals; some brands ST [e.g. fluconazole, itraconazole, terbinafine, posaconazole]
  • hiv antiretrovirals(Anthem Blue Cross (Elevance))No PAAnthem Blue Cross (Elevance) commercial formulary. All HIV antiretroviral subclasses (combos, integrase, protease, NNRTI, NRTI, NRTI-nucleotide, CCR5, fusion) carry QL only - NO PA, NO ST; open [e.g. abacavir-lamivudine, raltegravir (ISENTRESS), emtricitabine, tenofovir DF]
  • hepatitis c daa(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. Hepatitis C agents + combinations: PA + SP [e.g. EPCLUSA sofosbuvir-velpatasvir, PEGASYS peginterferon]
  • antifungals systemic(Anthem Blue Cross (Elevance))PA requiredAnthem Blue Cross (Elevance) commercial formulary. Triazoles + glucan synthesis inhibitors carry PA; imidazoles open [e.g. BREXAFEMME ibrexafungerp, voriconazole, posaconazole (triazoles)]
commercial qhp
  • antifungals systemic(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • hiv antiretrovirals(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • hepatitis c daa(Marketplace QHP (aggregate))PA requiredACA marketplace QHP — aggregated across the state's exchange issuers (PA if any issuer gates the class). Source: CMS machine-readable formulary PUF.
  • hepatitis c daa(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. Hep C agents and combinations carry PA
  • hiv antiretrovirals(Molina Healthcare)No PAMolina Healthcare commercial formulary. All ARV subsections (combos/integrase/protease/NNRTI/NRTI) QL/AGE only, no PA/ST
  • antifungals systemic(Molina Healthcare)PA requiredMolina Healthcare commercial formulary. Systemic triazole and one antifungal carry PA
If denied in Texas
📨 Program Support Unit (PSU)
Unlock the full pack

Full criteria, sources & appeal paths — all 51 states.

You’ve seen the breadth and one state in full. The complete Infectious Diseasepack — every state’s criteria, source citations, and step-by-step appeal instructions — is one email away.

We'll never sell or share your email.

Assembled from Auth57’s rules + criteria corpus + 51-state appeal layer. Draft data — verify against the payer’s current policy before relying.